{"schema_version":"secwatch.filing_event.v1","accession":"0000917520-24-000092","form_type":"8-K","ticker":"IART","cik":"0000917520","company_name":"INTEGRA LIFESCIENCES HOLDINGS CORP","filed_at":"2024-07-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.345831+00:00","generated_at":"2026-05-31T15:53:15.412612+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Integra LifeSciences Q2: GAAP loss $0.16/sh, adj EPS $0.63; cuts FY2024 guidance on compliance holds","bullets":["GAAP net loss $12.4M (-$0.16 diluted) vs prior year income $4.2M ($0.05). Adjusted EPS $0.63 vs $0.71.","Revenue $418.2M, up 9.7% reported, 2.3% organic; organic ex-Boston +0.3%. Adjusted gross margin 65.2% (down from 67.6%).","Codman Specialty Surgical rev $301.8M (+11.3% reported, +0.9% organic). Tissue Technologies $116.4M (+5.6% reported, +5.7% organic; -1% ex-Boston).","FY2024 guidance cut: revenue $1.609-1.629B, adjusted EPS $2.41-2.57. Cites temporary shipping holds and investments in quality/GMP compliance.","Received PMA approvable for SurgiMend pending GMP certification; Braintree facility operational readiness expected H1 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0000917520-24-000092","json":"https://secwatch.observer/filing/0000917520-24-000092.json","markdown":"https://secwatch.observer/filing/0000917520-24-000092.md","text":"https://secwatch.observer/filing/0000917520-24-000092.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000092/0000917520-24-000092-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000092/iart-20240729.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T15:53:15.412612+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}